A Closer Look At Marijuana Stocks With Alan Brochstein
March 25th, 2014
Last week Benzinga sat down with Alan Brochstein of the 420 Investor newsletter. He has been one of the first analysts to cover the sector in-depth and offered his valuable outlook on the budding industry.
Benzinga was interested in how long Brochstein had been approaching the industry from a technical and fundamental perspective. As it turns out, he has been covering the sector from both angles since February 2013.
It should be noted that Brochstein does not make any investments in the public market. He does this in order to remain objective on his coverage. His goal is to be unbiased in an attempt to disclose the information in a professional manner. By taking this approach, he puts his subscribers interest first.
With respect to technical analysis and charts, Brochstein believes the stocks in this sector are very much technically driven. He notices peaks and valleys in the stocks he covers, along with consolidation periods that are similar to what one would find in technical analysis textbooks.
“It’s a wild west right now. There’s not a lot of fundamental information; there’s a ton of money flowing into the market,” said Brochstein. “There are certain players that will all the sudden target stocks with low floats. That’s the market.”
In other words, his newsletter attempts to identify how and when the “big money” is moving in and out of issues in the sector.
With many of the issues being “penny stocks” with minimal Wall Street coverage, Brochstein was asked if the initiation of coverage by Bank of America on GW Pharmaceuticals (NASDAQ: GWPH) signaled a change of heart by the Street.
“GWPH is truly a biotech, and just happens to also be a marijuana stock. In no way do I think that signals them covering other companies. With the exception of GWPH and Cara Therapeutics (NASDAQ: CARA), Wall Street’s not going to be covering these stocks for a while.”
Brochstein added, the “penny stock conundrum is an issue. It’s an opportunity for some people. There are some good public companies now. Back when we launched they had market caps of 30-40 million. Institutional investors couldn’t touch these ‘cause they were penny stocks. Because of federal laws, these companies couldn’t go to banks to get loans, they couldn’t IPO with Morgan Stanley, so you do have a chance if you spend time to find the better companies in the space.
“The valuations have gotten so high that it makes sense for companies to become public. They typically become public through reverse merger. But there’s a NASDAQ IPO that’s going to blow everyone away.” Brochstein could not comment further on what this particular IPO would be.
Brochstein estimated at the beginning of 2014 that there were about 75,000-100,000 people invested in marijuana stocks. He expects this number to quickly multiply — so much so, that he has created the Marketfy 420 Investor Cannabis Stock Index. “People are going to be able to see how these stocks have been performing in the last year; they’re up 8X, but nobody has seen that.”
Benzinga asked if the current fervor has created a bubble, perhaps with the public is entering into the sector as the bubble is about to burst. “We’re definitely not at the tail end, but they could be paying too much. Now were starting to see what are the guys buying today, buy it up, then jump to the next stock. We’re seeing rotation.”
With respect to his experiences calling tops in bubbles, Brochstein said “I was shorting in late 1998 early 1999. When you say are we in a bubble, I say the beginning of bubble. I’ve learned to be a little more patient. SEC has halted two stocks and it’s had no impact on the sector.”
This is the first of a two-part interview. Check back soon for part two.
For those interested in further analysis on this new and controversial sector, visit the homepage for the 420 Investor.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.